Tapinarof Cream 1% Once Daily for Plaque Psoriasis: Long-Term Extension Trial of a Novel Therapeutic Aryl Hydrocarbon Receptor Modulating Agent. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s35, 2021. DOI: 10.25251/skin.5.supp.35. Disponível em: https://skin.dermsquared.com/skin/article/view/1386. Acesso em: 3 nov. 2025.